Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
13 Mar 24
DEFA14A
Additional proxy soliciting materials
13 Mar 24
DEF 14A
Definitive proxy
13 Mar 24
S-8
Registration of securities for employees
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Inari Medical Reports Fourth Quarter 2023 Financial Results
28 Feb 24
8-K
Departure of Directors or Certain Officers
23 Feb 24
8-K/A
Limflow Consolidated Financial Statements
31 Jan 24
8-K
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
9 Jan 24
8-K
Inari Medical Closes Acquisition of LimFlow
15 Nov 23
8-K
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
2 Nov 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Inari Medical Reports Third Quarter 2023 Financial Results
1 Nov 23
8-K
Departure of Directors or Certain Officers
22 Sep 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Inari Medical Reports Second Quarter 2023 Financial Results
2 Aug 23
SD
Conflict minerals disclosure
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
19 May 23
10-Q
2023 Q1
Quarterly report
3 May 23
8-K
Inari Medical Reports First Quarter 2023 Financial Results
3 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
S-8
Registration of securities for employees
27 Feb 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
27 Feb 23
8-K
Departure of Directors or Certain Officers
27 Jan 23
8-K
Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance
10 Jan 23
8-K
Entry into a Material Definitive Agreement
19 Dec 22
10-Q
2022 Q3
Quarterly report
2 Nov 22
8-K
Inari Medical Reports Third Quarter 2022 Financial Results
2 Nov 22
8-K
Regulation FD Disclosure
20 Sep 22
8-K
Inari Medical Announces Leadership Succession Plan
3 Aug 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
8-K
Inari Medical Reports Second Quarter 2022 Financial Results
3 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
27 May 22
10-Q
2022 Q1
Quarterly report
4 May 22
8-K
Inari Medical Reports First Quarter 2022 Financial Results
4 May 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
Latest ownership filings
4
William Hoffman
20 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
Mitch C. Hill,
14 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
4
Thomas Tu
21 Feb 24
4
Mitch C. Hill,
21 Feb 24
4
Andrew Hykes
21 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
MILDER DONALD B
8 Feb 24
SC 13G/A
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
4
Andrew Hykes
3 Jan 24
4
William Hoffman
3 Jan 24
4
Mitch C. Hill,
3 Jan 24
4
Thomas Tu
3 Jan 24
4
William Hoffman
19 Dec 23
4
DONALD B MILDER
15 Dec 23
4
Mitch C. Hill,
14 Dec 23
4
William Hoffman
6 Dec 23
4
Thomas Tu
17 Nov 23
4
Andrew Hykes
17 Nov 23
4
William Hoffman
17 Nov 23
4
Mitch C. Hill,
15 Nov 23
144
Notice of proposed sale of securities
15 Nov 23
144
Notice of proposed sale of securities
13 Nov 23
144
Notice of proposed sale of securities
13 Nov 23
4
DONALD B MILDER
8 Nov 23
4
William Hoffman
18 Oct 23
4
Mitch C. Hill,
16 Oct 23
144
Notice of proposed sale of securities
16 Oct 23
144
Notice of proposed sale of securities
12 Oct 23
4
William Hoffman
3 Oct 23
4
Andrew Hykes
3 Oct 23
4
Thomas Tu
3 Oct 23
4
Mitch C. Hill,
3 Oct 23
4
William Hoffman
19 Sep 23
144
Notice of proposed sale of securities
15 Sep 23
4
Mitch C. Hill,
14 Sep 23